CF PharmTech (2652) Announces Notice of 2025 First Extraordinary General Meeting

Bulletin Express11-26

CF PharmTech (2652) will hold its 2025 first extraordinary general meeting (EGM) on Tuesday, December 16, 2025, at 1 p.m. The meeting is scheduled to take place at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC.

According to the announcement, the EGM intends to consider and approve a Share Repurchase Mandate, the proposed adoption of an H Share Award Scheme, and authorization for the board and/or authorized person to handle matters related to the H Share Award Scheme. Shareholders are provided with a proxy form, and those who intend to vote through proxies should submit relevant documents in accordance with the outlined procedures.

The circular dated November 26, 2025, contains additional details regarding the resolutions. Shareholders planning to attend and vote at the EGM are advised to review the notice carefully, as it includes procedures on proxy appointments and documentation requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153471085?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-26 18:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153471085","market":"us","top_or_hot":-1,"title":"CF PharmTech (2652) Announces Notice of 2025 First Extraordinary General Meeting","media":"Bulletin Express","content":"<p>CF PharmTech (2652) will hold its 2025 first extraordinary general meeting (EGM) on Tuesday, December 16, 2025, at 1 p.m. The meeting is scheduled to take place at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC.</p>\n<p>According to the announcement, the EGM intends to consider and approve a Share Repurchase Mandate, the proposed adoption of an H Share Award Scheme, and authorization for the board and/or authorized person to handle matters related to the H Share Award Scheme. Shareholders are provided with a proxy form, and those who intend to vote through proxies should submit relevant documents in accordance with the outlined procedures.</p>\n<p>The circular dated November 26, 2025, contains additional details regarding the resolutions. Shareholders planning to attend and vote at the EGM are advised to review the notice carefully, as it includes procedures on proxy appointments and documentation requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech (2652) Announces Notice of 2025 First Extraordinary General Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech (2652) Announces Notice of 2025 First Extraordinary General Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-26 18:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech (2652) will hold its 2025 first extraordinary general meeting (EGM) on Tuesday, December 16, 2025, at 1 p.m. The meeting is scheduled to take place at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC.</p>\n<p>According to the announcement, the EGM intends to consider and approve a Share Repurchase Mandate, the proposed adoption of an H Share Award Scheme, and authorization for the board and/or authorized person to handle matters related to the H Share Award Scheme. Shareholders are provided with a proxy form, and those who intend to vote through proxies should submit relevant documents in accordance with the outlined procedures.</p>\n<p>The circular dated November 26, 2025, contains additional details regarding the resolutions. Shareholders planning to attend and vote at the EGM are advised to review the notice carefully, as it includes procedures on proxy appointments and documentation requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1153471085","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153471085","pubTimestamp":1764153692,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech (2652) will hold its 2025 first extraordinary general meeting (EGM) on Tuesday, December 16, 2025, at 1 p.m. The meeting is scheduled to take place at No. 16, Hucundang Road, Xiangcheng...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech(2652)公布2025年第一次临时股东大会通告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech (2652) will hold its 2025 first extraordinary general meeting (EGM) on Tuesday, December 16, 2025, at 1 p.m. The meeting is scheduled to take place at No. 16, Hucundang Road, Xiangcheng Economic Development District, Suzhou, Jiangsu, PRC.\nAccording to the announcement, the EGM intends to consider and approve a Share Repurchase Mandate, the proposed adoption of an H Share Award Scheme, and authorization for the board and/or authorized person to handle matters related to the H Share Award Scheme. Shareholders are provided with a proxy form, and those who intend to vote through proxies should submit relevant documents in accordance with the outlined procedures.\nThe circular dated November 26, 2025, contains additional details regarding the resolutions. Shareholders planning to attend and vote at the EGM are advised to review the notice carefully, as it includes procedures on proxy appointments and documentation requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153471085","isCrawlerRequest":true}